168827-91-6

Basic information

• Product Name: (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester
• Synonyms: (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester
• CAS NO: 168827-91-6
• Molecular Weight: 223.272
• Mol File: 168827-91-6.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester(168827-91-6)
• EPA Substance Registry System: (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester(168827-91-6)

Safety Data

• Hazardous Substances Data: 168827-91-6(Hazardous Substances Data)

Usage

Description

(3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester is a chemical compound with the chemical formula C12H17NO3. It is an ester derivative of carbamic acid, containing a benzyl group attached to the carbamate functional group. (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester is known for its unique chemical structure and properties, which make it a promising candidate for various applications in organic synthesis and pharmaceutical research.

Uses

Used in Organic Synthesis:
(3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester is used as a reagent in organic synthesis for the preparation of various organic compounds. Its unique chemical structure allows for versatile reactions and the formation of a wide range of products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester is used as an intermediate in the synthesis of new medications. Its potential as a drug or pharmaceutical ingredient is being explored for the development of innovative treatments.
Used in Medicinal Applications:
Due to its unique chemical properties, (3-hydroxy-1-(S)-methyl-propyl)carbamic acid benzyl ester exhibits strong potential for medicinal applications. It is being investigated for its possible use in the treatment of various diseases and conditions, offering new avenues for therapeutic intervention.

Upstream product

• 61477-39-2 (+)-(S)-3-aminopropan-1-ol 
• 501-53-1 benzyl chloroformate 
• 174743-89-6 (+/-)-3-<(Benzyloxycarbonyl)amino>butan-1-ol 
• 65638-93-9 N-Carbobenzoxy-L-alanin-kohlensaeureaethylesteranhydrid 
• 51440-81-4 3-benzyloxycarbonylaminobutyric acid 
• 878999-34-9 (1-(S)-methyl-allyl)carbamic acid benzyl ester 
• 67865-68-3 benzyl (S)-(4-diazo-3-oxobutan-2-yl)carbamate 
• 1142-20-7 N-Cbz-Ala 
• 83509-88-0 (S)-3-benzyloxycarbonylaminobutyric acid 

Downstream Products

• 1558-58-3 (6S)-(+)-6-methylpiperidin-2-one 
• 1263099-47-3 [3-(tert-butyl-silanoxy)-1-(S)-methyl-propyl]carbamic acid benzyl ester 
• 1616868-40-6 (S)-3-(benzyloxycarbonylamino)butyl methanesulfonate 
• 1616868-53-1 (S)-S-3-(benzyloxycarbonylamino)butyl ethanethioate 
• 1616868-61-1 (S)-3-benzyloxycarbonylaminobutane-1-sulfonic acid 

Relevant articles and documents

A optically active 3 - amino butanol and 3 - aminobutyric acid preparation method (by machine translation)

The invention discloses a method of optically active 3 - amino butanol and 3 - aminobutyric acid preparation method. Wherein optically active 3 - amino butyl alcohol preparation method comprises the following steps: in a solvent, in the borohydride reducing agent and a Lewis acid under the action of the, shown as 65 shown in the reduction reaction of compound, production like type 14 indicated by the compound. Optically active 3 - aminobutyric acid preparation method comprises the following steps: shown as 64 a compound represented by the hydrolytic reaction, production like type 65 compound of formula. Preparation method of this invention the raw material is cheap, simple operation, the process route is short, the raw material is not hazardous, high yield, produce little material waste, is beneficial for the protection of the environment, high conversion rate of raw materials, product chemical purity and high optical purity, and is easy to realize industrial. (by machine translation)

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

Compounds of the formula I, or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, X1, X2, X3, X4, Y, Z, A, Het, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein.. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis, muscular sclerosis and psoriasis.

ARYL SULTAM DERIVATIVES AS RORc MODULATORS

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, W, X1, X2, X3, X4, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.